Mark Tyndall

21.2k total citations · 2 hit papers
263 papers, 16.2k citations indexed

About

Mark Tyndall is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mark Tyndall has authored 263 papers receiving a total of 16.2k indexed citations (citations by other indexed papers that have themselves been cited), including 209 papers in Epidemiology, 120 papers in Infectious Diseases and 82 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mark Tyndall's work include HIV, Drug Use, Sexual Risk (162 papers), HIV/AIDS Research and Interventions (111 papers) and Opioid Use Disorder Treatment (74 papers). Mark Tyndall is often cited by papers focused on HIV, Drug Use, Sexual Risk (162 papers), HIV/AIDS Research and Interventions (111 papers) and Opioid Use Disorder Treatment (74 papers). Mark Tyndall collaborates with scholars based in Canada, United States and Australia. Mark Tyndall's co-authors include Evan Wood, Thomas Kerr, Julio Montaner, Robert S. Hogg, Martin T. Schechter, Kate Shannon, Kathy Li, Michael V. O’Shaughnessy, Steffanie A. Strathdee and Jean Shoveller and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mark Tyndall

257 papers receiving 15.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review

2008 1.0k citations Mark Tyndall et al. profile →
Opioid use disorder

2020 354 citations Mark Tyndall et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Mark Tyndall	12.6k	6.5k	5.3k	3.4k	3.0k	263	16.2k
Don C. Des Jarlais	16.1k 1.3×	9.8k 1.5×	5.0k 0.9×	3.5k 1.0×	5.2k 1.7×	525	21.6k
Tim Rhodes	10.3k 0.8×	5.8k 0.9×	3.1k 0.6×	4.1k 1.2×	3.2k 1.1×	264	13.2k
Martin T. Schechter	8.5k 0.7×	5.8k 0.9×	4.3k 0.8×	1.8k 0.5×	2.6k 0.8×	373	15.8k
Frederick L. Altice	10.4k 0.8×	9.4k 1.5×	3.3k 0.6×	3.0k 0.9×	3.5k 1.2×	463	15.5k
Evan Wood	20.6k 1.6×	12.0k 1.9×	11.3k 2.1×	4.5k 1.3×	6.4k 2.1×	694	28.6k
Thomas Kerr	21.1k 1.7×	9.4k 1.5×	11.8k 2.2×	6.2k 1.8×	6.9k 2.3×	725	28.1k
Peter Vickerman	11.4k 0.9×	5.5k 0.9×	2.8k 0.5×	1.9k 0.6×	1.6k 0.5×	394	14.6k
Lisa Maher	7.5k 0.6×	3.1k 0.5×	2.2k 0.4×	2.7k 0.8×	2.0k 0.7×	375	10.7k
Josiah D. Rich	5.9k 0.5×	2.7k 0.4×	3.8k 0.7×	2.1k 0.6×	2.0k 0.7×	320	9.9k
David D. Celentano	9.0k 0.7×	8.6k 1.3×	1.6k 0.3×	3.9k 1.1×	5.6k 1.9×	370	15.7k

Countries citing papers authored by Mark Tyndall

Since Specialization

Citations

This map shows the geographic impact of Mark Tyndall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Tyndall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Tyndall more than expected).

Fields of papers citing papers by Mark Tyndall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Tyndall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Tyndall. The network helps show where Mark Tyndall may publish in the future.

Co-authorship network of co-authors of Mark Tyndall

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Tyndall. A scholar is included among the top collaborators of Mark Tyndall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Tyndall. Mark Tyndall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kendall, Claire, Lisa M. Boucher, Jessy Donelle, et al.. (2020). Engagement in primary health care among marginalized people who use drugs in Ottawa, Canada. BMC Health Services Research. 20(1). 20 indexed citations

Janjua, Naveed Z., Maryam Darvishian, Stanley Wong, et al.. (2019). Effectiveness of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in People Who Inject Drugs and/or Those in Opioid Agonist Therapy. Hepatology Communications. 3(4). 478–492. 22 indexed citations

Darvishian, Maryam, Stanley Wong, Mawuena Binka, et al.. (2019). Loss to follow‐up: A significant barrier in the treatment cascade with direct‐acting therapies. Journal of Viral Hepatitis. 27(3). 243–260. 23 indexed citations

Krajden, Mel, Darrel Cook, Stanley Wong, et al.. (2019). What is killing people with hepatitis C virus infection? Analysis of a population-based cohort in Canada. International Journal of Drug Policy. 72. 114–122. 16 indexed citations

Darvishian, Maryam, Naveed Z. Janjua, Mei Chong, et al.. (2018). Estimating the impact of early hepatitis C virus clearance on hepatocellular carcinoma risk. Journal of Viral Hepatitis. 25(12). 1481–1492. 8 indexed citations

Butt, Zahid A, Sunny Mak, Dionne Gesink, et al.. (2018). Applying core theory and spatial analysis to identify hepatitis C virus infection “core areas” in British Columbia, Canada. Journal of Viral Hepatitis. 26(3). 373–383. 3 indexed citations

Pakhalé, Smita, et al.. (2018). Management and Point-of-Care for Tobacco Dependence (PROMPT): a feasibility mixed methods community-based participatory action research project in Ottawa, Canada. BMJ Open. 8(1). e018416–e018416. 11 indexed citations

Martel‐Laferrière, Valérie, Roy Nitulescu, Joseph Cox, et al.. (2017). Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study. BMC Infectious Diseases. 17(1). 80–80. 6 indexed citations

Calzavara, Liviana, et al.. (2016). A Comparison of Web and Telephone Responses From a National HIV and AIDS Survey. JMIR Public Health and Surveillance. 2(2). e37–e37. 22 indexed citations

10.

Islam, Md. Nazrul, Mel Krajden, Jean Shoveller, et al.. (2016). Impact of drug use and opioid substitution therapy on hepatitis C reinfection: The BC Hepatitis Testers Cohort. Hepatology. 63. 4 indexed citations

11.

Worthington, Catherine, et al.. (2015). Individual and jurisdictional factors associated with voluntary HIV testing in Canada: Results of a national survey, 2011. Canadian Journal of Public Health. 106(2). e4–e9. 5 indexed citations

12.

Fischer, Benedikt, Cayley Russell, & Mark Tyndall. (2015). Cannabis vaping and public health—some comments on relevance and implications. Addiction. 110(11). 1705–1706. 9 indexed citations

13.

Deering, Kathleen, et al.. (2009). Piloting a Peer-Driven Intervention Model to Increase Access and Adherence to Antiretroviral Therapy and HIV Care among Street-Entrenched HIV-Positive Women in Vancouver. AIDS Patient Care and STDs. 23(8). 603–609. 79 indexed citations

14.

Wood, Evan, Mark Tyndall, Kathy Li, et al.. (2005). Do Supervised Injecting Facilities Attract Higher-Risk Injection Drug Users?. American Journal of Preventive Medicine. 29(2). 126–130. 104 indexed citations

15.

Wild, T. Cameron, Nady el‐Guebaly, Benedikt Fischer, et al.. (2005). Comorbid Depression among Untreated Illicit Opiate Users: Results from a Multisite Canadian Study. The Canadian Journal of Psychiatry. 50(9). 512–518. 32 indexed citations

16.

Kerr, Thomas, Evan Wood, Dan Small, Anita Palepu, & Mark Tyndall. (2003). Potential use of safer injecting facilities among injection drug users in Vancouver's Downtown Eastside.. PubMed. 169(8). 759–63. 88 indexed citations

17.

Wood, Evan, Julio Montaner, Benita Yip, et al.. (2003). Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users.. PubMed. 169(7). 656–61. 193 indexed citations

18.

Wood, Evan, Mark Tyndall, & Martin T. Schechter. (2003). Drug supply and drug abuse.. Canadian Medical Association Journal. 168(9). 1113–1113. 1 indexed citations

19.

Palepu, Anita, Mark Tyndall, Hernando León, et al.. (2001). Hospital utilization and costs in a cohort of injection drug users.. PubMed. 165(4). 415–20. 225 indexed citations

20.

Tyndall, Mark, Shaheed Vally Omar, Kelly S. MacDonald, et al.. (1999). A Randomized, Double‐Blind, Placebo‐Controlled Trial of Single‐Dose Ciprofloxacin versus Erythromycin for the Treatment of Chancroid in Nairobi, Kenya. The Journal of Infectious Diseases. 180(6). 1886–1893. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact